A Day Up For XTL Biopharmaceuticals Ltd.
Wed, Mar 20, 2024 at 07:30 PM
XTL Biopharmaceuticals Ltd. (XTLB:NASDAQ) soared at $2.38, representing a gain of 131.1%. On Wed, Mar 20, 2024, XTLB:NASDAQ touched a New 2-Week High of $2.38. From Wed, Mar 06, 2024, the stock recorded 44.44% Up Days and 50.00% Green Days
About XTL Biopharmaceuticals Ltd. (XTLB:NASDAQ)
XTL Biopharmaceuticals Ltd is engaged in the acquisition & development of pharmaceutical drugs for the treatment of unmet medical needs, currently for the treatment of schizophrenia and Hepatitis C. It has also developed a home therapeutic device.
Top 10 Gainers:
- Republic First Bancorp, Inc. (FRBK:NASDAQ), 280.95%
- XTL Biopharmaceuticals Ltd. (XTLB:NASDAQ), 131.07%
- SRAX, Inc. (SRAX:NASDAQ), 90%
- Etao International Co. Ltd. (ETAO:NASDAQ), 88.81%
- TruGolf Inc Cl A (TRUG:NASDAQ), 64.35%
- Cazoo Group Ltd Class A (CZOO:NYSE), 63.85%
- Anghami Inc. (ANGH:NASDAQ), 59%
- Brainstorm Cell Therapeutics Inc. (BCLI:NASDAQ), 42.54%
- AEye Inc. (LIDR:NASDAQ), 41.9%
- Theriva Biologics Inc Com Par $.001 (TOVX:NYSEMKT), 39.95%